End-to-End Single-Site Solution from Drug Substances to Fill-Finish & Packaging
TOKYO, January 6, 2021― FUJIFILM Corporation (President: Kenji Sukeno) is making an investment of more than 200 Billion yen (2 Billion USD) to establish a new large-scale cell culture production site in the United States to accelerate the growth of its biopharmaceutical contract development and manufacturing business (CDMO).